Respiratorius AB (publ)

Research Respiratorius AB (publ) (HF00) on Bullrun: market cap EUR 1.54M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerHF00
ExchangeF
CountrySweden
SectorHealthcare
IndustryBiotechnology
CurrencyEUR
Market capEUR 1.54M
Financial periodQ1 2026
RevenueSEK 11.00K
Net income-SEK 1.73M
Free cash flow-SEK 1.28M
Gross margin10209.1%

Valuation Snapshot

latest market cap is EUR 1.54M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	SEK 30.00K	-SEK 6.95M	-SEK 2.74M	14470.0%	-1.13	n/a	n/a	SEK 30.61M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-23	EUR 1.54M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Respiratorius AB (publ)

Respiratorius AB (publ), a research company, develops pharmaceuticals for the treatment of cancer. The company's products under development include VAL001, that is in Phase III clinical trials for the treatment of diffuse large B-cell lymphoma; and VAL001, a product candidate that is in preclinical phase for the treatment of relapsing diffuse large B-cell lymphoma. Respiratorius AB (publ) was incorporated in 1998 and is based in Lund, Sweden.

Related stock research

Sweden stocks Sweden Healthcare stocks A-Z stock index

Other Healthcare stocks

Camurus AB (0RD1) Flerie AB (publ) (1NP1) GENOVIS AB SE-40 (5GV) Fluicell AB (publ) (5J90) ExpreS2ion Biotech Holding AB (publ) (5JD0) ALZINOVA AB (78D) 7AL0 (7AL0) ASCELIA PHARMA AB (7ZA) Biosergen AB (8N10) ABERA BIOSCIENCE AB (8WK) Ascelia Pharma AB (publ) (ACE) AcouSort AB (ACOU)

Frequently asked questions

What is Respiratorius AB (publ)'s market cap?

Respiratorius AB (publ)'s market capitalization is EUR 1.54M.